COMP <GO>
PDEX vs STIM // RETURN ON INVESTED CAPITAL (ROIC)
Pro-Dex Inc. (NASDAQ) VS. Neuronetics Inc. (NASDAQ) • 15-METRIC TALLY: PDEX 6
— STIM 3
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: PDEX
LAST: $61.60 (-2.52%) • MKT CAP: $199.2M
roic
23.20%
LAST: $2.38 (+5.31%) • MKT CAP: $181.3M
roic
-35.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PDEX VS. STIM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PDEX | STIM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 29.30% | 48.50% | -19.20 | STIM | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 23.20% | -35.00% | +58.20 | PDEX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.5x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -1.47% | -11.25% | +9.78 | PDEX | /fcf-yield <GO> |
| Operating Margin | 16.10% | -21.10% | +37.20 | PDEX | /operating-margins <GO> |
| Net Profit Margin | 13.50% | -26.10% | +39.60 | PDEX | /net-margins <GO> |
| Revenue Growth (YoY) | 23.70% | 99.20% | -75.50 | STIM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 9.08 | 0.20 | +8.88 | PDEX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 5/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 38.5 | 50.1 | -11.51 | STIM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.6x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $199.2M | $181.3M | $17.8M | PDEX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PDEX REV | STIM REV | PDEX GROSS % | STIM GROSS % | PDEX FCF | STIM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $66.6M | $149.2M | 29.3% | 48.5% | -$2.9M | -$20.4M |
| FY 2024 | $53.8M | $74.9M | 27.0% | 72.3% | $6.2M | -$31.0M |
| FY 2023 | $46.1M | $71.3M | — | — | $5.5M | -$32.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PDEX // BETA —
STIM // BETA —